We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+5.57%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$999B
AUM Growth
+$24.7B
Cap. Flow
-$14B
Cap. Flow %
-1.41%
Top 10 Hldgs %
24.27%
Holding
2,908
New
248
Increased
1,171
Reduced
1,334
Closed
66

Top Buys

Rank Stock Value
1
ZM icon
Zoom
ZM
+$3.3B
2
LLY icon
Eli Lilly
LLY
+$2.75B
3
AZN icon
AstraZeneca
AZN
+$1.98B
4
CPNG icon
Coupang
CPNG
+$1.54B
5
FTNT icon
Fortinet
FTNT
+$1.48B

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$2.34B
2
MS icon
Morgan Stanley
MS
+$2.26B
3
ABNB icon
Airbnb
ABNB
+$2.04B
4
QCOM icon
Qualcomm
QCOM
+$1.95B
5
NVDA icon
NVIDIA
NVDA
+$1.81B

Sector Composition

Rank Sector Weight
1 Technology 23.35%
2 Healthcare 16.19%
3 Consumer Discretionary 15.55%
4 Financials 12.84%
5 Communication Services 12.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRPC.U
2526
DELISTED
CC Neuberger Principal Holdings III Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
PRPC.U
$325K ﹤0.01%
+32,486
New +$335K
AVXL icon
2527
Anavex Life Sciences
AVXL
$299M
$324K ﹤0.01%
21,642
-44,350
-67% -$484K
PKE icon
2528
Park Aerospace
PKE
$806M
$324K ﹤0.01%
24,530
+3,529
+17% +$49.7K
AAIC
2529
DELISTED
Arlington Asset Investment Corp.
AAIC
$324K ﹤0.01%
80,112
+11,537
+17% +$45.5K
WASH icon
2530
Washington Trust Bancorp
WASH
$765M
$323K ﹤0.01%
6,250
+12
+0.2% +$582
JAMF
2531
DELISTED
Jamf
JAMF
$322K ﹤0.01%
+9,122
New +$333K
EAF icon
2532
GrafTech
EAF
$207M
$321K ﹤0.01%
2,625
+894
+52% +$103K
UFPT icon
2533
UFP Technologies
UFPT
$2.52B
$321K ﹤0.01%
6,452
-661
-9% -$32.3K
NHC icon
2534
National Healthcare
NHC
$3.47B
$320K ﹤0.01%
4,101
-46
-1% -$3.25K
TRS icon
2535
TriMas Corp
TRS
$1.41B
$320K ﹤0.01%
10,566
-1,508
-12% -$49.7K
COHN icon
2536
Cohen & Co
COHN
$38.5M
$318K ﹤0.01%
13,400
GIC icon
2537
Global Industrial
GIC
$1.48B
$317K ﹤0.01%
7,712
-8,357
-52% -$330K
TILE icon
2538
Interface
TILE
$2.24B
$315K ﹤0.01%
25,240
+31
+0.1% +$368
CBAY
2539
DELISTED
Cymabay Therapeutics
CBAY
$315K ﹤0.01%
69,335
+21,377
+45% +$115K
CSTL icon
2540
Castle Biosciences
CSTL
$952M
$314K ﹤0.01%
4,580
+679
+17% +$51K
SCPL
2541
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
$314K ﹤0.01%
19,392
NRC icon
2542
NRC Health Common Stock
NRC
$459M
$312K ﹤0.01%
+6,662
New +$324K
CLB icon
2543
Core Laboratories
CLB
$570M
$311K ﹤0.01%
10,800
FCBC icon
2544
First Community Bankshares
FCBC
$931M
$311K ﹤0.01%
10,386
+13
+0.1% +$331
VYGR icon
2545
Voyager Therapeutics
VYGR
$201M
$308K ﹤0.01%
+65,378
New +$446K
AFMD
2546
DELISTED
Affimed
AFMD
$306K ﹤0.01%
3,870
+201
+5% +$13K
VVNT
2547
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
$306K ﹤0.01%
21,345
+3,991
+23% +$72.6K
ADMS
2548
DELISTED
Adamas Pharmaceuticals
ADMS
$306K ﹤0.01%
63,700
IVC
2549
DELISTED
Invacare Corporation
IVC
$305K ﹤0.01%
38,017
-8,498
-18% -$79.2K
AAWW
2550
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
$305K ﹤0.01%
5,053
-9
-0.2% -$503

Similar funds

T. Rowe Price Associates's Q1 2021 Portfolio in Review

As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
  • T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
  • T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
  • T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
  • T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
  • T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
  • T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.

Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.